Encephalopathies of Critical Conditions: Problem and Solutions
https://doi.org/10.30629/2658-7947-2020-25-4-51-59
Abstract
Cerebral insufficiency accompanies all conditions associated with the development of critical states arising from acute diseases, including infectious ones. The causes of cerebral disorders in critical states, regardless of their genesis, are multifactorial and are characterized by progression of cerebral blood flow insufficiency, cerebral ischemia, which results in the formation of critical state encephalopathies with neurological deficit, as well as a decrease in cognitive functions in the outcome of the disease. The article defines the concept of encephalopathy of a critical state, deals with the main causes and mechanisms leading to its development, and clinical manifestations. The data of our own study of 30 children with critical state encephalopathies in various infectious diseases are presented. Neurofunctional changes in patients with critical state encephalopathies are described. Recommendations on the tactics of maintaining reconvalescents with encephalopathies of critical condition are given.
About the Authors
N. V. Skripchenkko
Pediatric Research and Clinical Center for Infectious Diseases; Saint Petersburg State Pediatric Medical University
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
A. A. Vilnits
Pediatric Research and Clinical Center for Infectious Diseases; Saint Petersburg State Pediatric Medical University
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
E. S. Egorova
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
A. V. Klimkin
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
V. B. Voitenkov
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
M. A. Bedova
Pediatric Research and Clinical Center for Infectious Diseases
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
References
1. Iskander K., Osuchowski M., Stearns-Kurosawa D., Kurosawa S., Stepien D., Valentine C. et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol. Rev. 2013;93(3):1247–1288. https://doi.org/10.1152/physrev.00037.2012
2. Jones K. Delirium in febrile conditions. Dublin. J. Med. Sci. 1903;115:420–422. https://doi.org/10.1007/bf02965359
3. Ebersoldt M., Sharshar T., Annane D. Sepsis-associated delirium. Intensive Care Med. 2007;33:941–950. https://doi.org/10.1007/s00134-007-0622-2
4. Botkin S.P. Clinical lectures given at the Military Medical Academy in 1883–1888 SPb.;1912. (in Russ.).
5. Dellinger R.P., Levy M.M., Carlet J.M., Bion D., Parker M.M., Jaeschke R. et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock. Crit. Care Med. 2008;36:296–327. https://doi.org/10.1097/CCM.0000000000002255
6. Fesenko O.V., Sinopal’nikov A.I., Filatov V.V., Danishevsky S.V., Styrt E.A. Clinical aspects of septic encephalopathy. Klin. med. 2016;94(1):67–70. https://doi.org/10.18821/0023-2149-2016-94-1-67-70 (in Russ.).
7. Neufeld K.J., Thomas C. Delirium: Definition, Epidemiology, and Diagnosis. Journal of Clinical Neurophysiology. 2013;30(5):438–442. https://doi.org/10.1097/WNP.0b013e3182a73e31
8. Salmina A.B., Fursov A.A., Mikhutkin S.V., Shahmaeva S.V., Mantorova N.S. Disorders of NAD metabolism in neuronal dysfunction in critical states. Obshchaya reanimatologiya. 2008;4(1):80–81 (in Russ.). https://doi.org/10.15360/1813-9779-2008-1-80
9. Hoshino A., Saitoh M., Oka A., Okumura A., Mizuguchi M. Epidemiology of acute encephalopathy in Japan, with emphasis on the as sociation of viruses and syndromes. Brain & Development. 2012;34:337–343. https://doi.org/10.1016/j.braindev.2011.07.012
10. Halpern L.A., Agyeman P., Steinlin M., El-Koussy M., Grunt S. Mild E.ncephalopathy With Splenial Lesion and Parainfluenza Virus Infection. Pediatric Neurology 2013;48:252–254. https://doi.org/10.1016/j.pediatrneurol.2012.11.007
11. Hazama K., Shiihara T., Tsukagoshi H., Matsushige T., Dowa Y., Watanabe M. Rhinovirus-associated acute encephalitis/encephalopathy and cerebellitis. Brain & Development. 2019;41:551–554. https://doi.org/10.1016/j.braindev.2019.02.014
12. Tabarki B., Thabet F., Al Shafi S., Al Adwani N., Chehab M., Al Shahwan S. Acute necrotizing encephalopathy associated with enterovirus infection. Brain & Development. 2013;35(5):454–457. https://doi.org/10.1016/j.braindev.2012.07.001
13. Lee W.S., Ou T.Y., Chen F.L., Hsu C.W., Jean S.S. Severe Mycoplasma pneumoniae Infection Complicating Septic Encephalopathy and Seizure Attacks. J. Exp. Clin. Med. 2014;6(2):68–69. https://doi.org/10.1016/j.jecm.2014.02.004
14. Zhang S., Feng J., Shi Y. Transient widespread cortical and splenial lesions in acute encephalitis/encephalopathy associated with primary Epstein–Barr virus infection. International Journal of Infectious Diseases. 2016;42:7–10. https://doi.org/10.1016/j.ijid.2015.11.009
15. Weiss N., Junot C., Rudler M., Thabut D. Hepatic versus drug-induced encephalopathy in cirrhotic patients? Liver Int. 2016;36(8):1233–1236. https://doi.org/10.1111/liv.13061
16. Assaraf J., Weiss N., Thabut D. Proton pump inhibitor administration triggersencephalopathy in cirrhotic patients by modulating blood-brain barrier drugtransport. Gastroenterology. 2017;152(8):2077. https://doi.org/10.1053/j.gastro.2016.10.049
17. Hosokawa K., Gaspard N., Su F., Oddo M., Vincent J.L., Taccone F.S. Clinical neurophysiological assessment of sepsisassociated brain dysfunction: a systematic review. Crit. Care. 2014;18(6):674. https://doi.org/10.1186/s13054-014-0674-y
18. Feng Q., Wu L., Ai Y.H., Deng S.Y., Ai M.L., Deng S. et al. The diagnostic value of neuron-specific enolase, central nervous system specific protein and interleukin-6 in sepsis-associated encephalopathy. Zhonghua Nei Ke Za Zhi. 2017;56:747–751. https://doi.org/10.3760/cma.j.issn.0578-1426.2017.10.008
19. Hsu A.A., Fenton K., Weinstein S., Carpenter J., Dalton H., Bell M.J. Neurological injury markers in children with septic shock. Pediatr. Crit. Care Med. 2008;9(3):245–251. https://doi.org/10.1097/pcc.0b013e3181727b22
20. Anderson B.J., Reilly J.P., Shashaty M.G.S., Palakshappa J.A., Wysoczanski A., Dunn T.G. et al. Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis. J. Crit. Care. 2016;36:18–23. https://doi.org/10.1016/j.jcrc.2016.06.012
21. Ehlera J., Sallerb T., Wittstockc M., Rommerd P.S., Chappell D., Zwissler B. et al. Diagnostic value of NT-proCNP compared to NSE and S100b in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy. Neuroscience Letters. 2019;692:167–173. https://doi.org/10.1016/j.neulet.2018.11.014
22. Schouten B.J., Prickett T.C., Hooper A.A., Hooper G.J., Espiner E.A. Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid. Peptides. 2011;32(4):797–804. https://doi.org/10.1016/j.peptides.2011.01.013
23. Tumanskij V.A., Tumanskaya N.V. Natriuretic peptides: biogenesis, functions and role in pathology. Patologiya. 2008;5(4):4–13. (in Russ.). http://nbuv.gov.ua/UJRN/pathology_2008_5_4_3
24. Osterbur K., Yu D.H., DeClue A.E. Interleukin-1β, tumour necrosis factor-α and lipopolysaccharide induce C-type natriuretic peptide from canine aortic endothelial cells. Res. Vet. Sci. 2013;94 (3):478–483. https://doi.org/10.1016/j.rvsc.2012.10.002
25. Koziorowski D., Tomasiuk R., Szlufi k S., Friedman A. Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients. Cytokine. 2012;60(3):762–766. https://doi.org/10.1016/j.cyto.2012.07.030
26. Decker J.M., Wójtowicz A.M., Bartsch J.C., Liotta A., Braunewell K.H., Heinemann U. et al. C-type natriuretic peptide modulates bidirectional plasticity in hippocampal area CA1 in vitro. Neuroscience. 2010;169(1):8–22. https://doi.org/10.1016/j.neuroscience.2010.04.064
27. Bíró E., Tóth G., Telegdy G. Effect of receptor blockers on brain natriuretic peptide and C-type natriuretic peptide caused anxiolytic state in rats. Neuropeptides. 1996;30:59–65. https:// doi: 10.1016/s0143-4179(96)90056-6
28. Heming N., Mazeraud A., Verdonk F., Bozza F.A., Chrétien F., Sharshar T. Neuroanatomy of sepsis-associated encephalopathy. Crit. Care. 2017;21(1):65. https://doi.org/10.1186/s13054-017-1643-z
29. Duncan C.C., Barry R.J., Connolly J.F., Fischer C., Michie P.T., Näätänen R. et al. Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin. Neurophysiol. 2009;120(11):1883–1908. https://doi.org/10.1016/j.clinph.2009.07.045
30. Guerit J.M. Neurophysiological testing in neurocritical care. Curr. Opinion Crit. Care. 2010;16(2):98–104. https://doi.org/10.1097/mcc.0b013e328337541a
31. Oddo M., Rossetti A.O. Early multimodal outcome prediction after cardiac arrest in patients treated with hypothermia. Crit. Care Med. 2014;42(6):1340–1347. https://doi.org/10.1097/ccm.0000000000000211
32. Nevalainen P., Marchi V., Metsäranta M., Lönnqvist T., Toiviainen-Salo S., Vanhatalo S. et al. Evoked potentials recorded during routine EEG predict outcome after perinatal asphyxia. Clin. Neurophysiol. 2017;128(7):1337–1343. https://doi.org/10.1016/j.clinph.2017.04.025
33. The research committee on the clarification of etiology and on the establishment of therapeutic and preventive measures of influenza encephalopathy, Guideline for Influenza Encephalopathy, Ministry of Health, Labor and Welfare, Japan, 2009;1–22.
34. Kamchatnov P.R., CHugunov A.V., Osmaeva Z.H. Cytoflavin: Metabolic Therapy in Patients with Dyscirculatory Encephalopathy. Doktor.Ru. 2019;1(156):14–19. (in Russ.). https://doi:10.31550/1727-2378-2019-156-1-14-19
35. Scripchenko N.V., Egorova E.S. Cytoflavin in the complex treatment of neuroinfections in children. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2011;111(9):28–31. (in Russ.). https://www.mediasphera.ru/issues/zhurnal-nevrologiii-psikhiatrii-im-s-s-korsakova/2011/9/031997-7298201195
36. Scripchenko N.V., Ivanova G.P., Scripchenko E.Yu., Egorova E.S., Surovceva A.V. Cytoflavin efficacy in the treatment of disseminated encephalomyelitis in children. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. Speczvypuski. 2017;117(11):67–74. (in Russ.). https://doi:10.17116/jnevro201711711267-74
37. Rumyanceva S.A., Fedin A.I., Bolevich S.B., Silina E.V., Vasil’ev Yu.D., Men’shova N.I. et al. Effect of early correction of energy and free-radical homeostasis on the clinical-morphological presentation of cerebral infarction. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2010;110(8):16–21. (in Russ.). https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2010/8/031997-7298201083
38. Mazin P.V., Sheshunov I.V., Mazina N.K. Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;3:28–39. (in Russ.). https://doi:10.17116/jnevro20171173128-39
39. Maevskii E.I., Grishina E.V., Rozenfel’d A.S., Zyakun A.M., Vereshchagina V.M., Kondrashova M.N. Anaerobic formation of succinate and ensuring its oxidation are possible mechanisms of cell adaptation to oxygen starvation. Biofizika. 2000;45(3):509–513. (in Russ.). https://www.medline.ru/public/art/tom1/art3.phtml
40. Silina E.V., Rumyantseva S.A., Bolevich S.B., Menshova N.I. Сourse of free radical processes and prognosis of ischemic and hemorrhagic stroke. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2011;12(2):36–42. (in Russ.). https://studylib.ru/doc/2687462/zakonomernosti-techeniya-svobodnoradikal._nyh
41. Rumyantseva S.A., Silina E.V., Chichanovskaya L.V., Nazarov M.V., Tsukurov L.A., Kovalenko A.L. et al. Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;114(10):49–55. (in Russ.) https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2014/10/031997-72982014109
42. Kovalchuk V.V. Therapeutic possibilities of improvement of cognitive functions, psychoemotional condition and a quality of life in post-stroke patients. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015;115(12):92–97. (in Russ.). https://doi:10.17116/jnevro201511511292-97
43. Madzhidova E.N., Usmanova D.D., Bajtursunova Zh.M. Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2012;112(9):57–62 (in Russ.). https://www.mediasphera.ru/issues/zhurnal-nevrologiii-psikhiatrii-im-s-s-korsakova/2012/9/downloads/ru/031997-72982012910
44. Erkebaeva S.K., Nurguzhaev E.S., Gafurov B.G., Tuksanbaeva G.U. The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2012;112(11):32–36.(in Russ.). https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2012/11/downloads/ru/031997-729820121106
45. Gatckikh I.V., Veselova O.F., Brickman I.N., Shalda T.P., Varygina E.L.,Kuznecov M.N., Narkevich A.N., Petrova M.M. Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy. Klin. med. 2016;94(7):533–539. (in Russ.). https://doi:10.18821/0023-2149-2016-94-7-533-539
46. Rumyanceva S.A., Kovalenko A.L., Silina E.V., Stupin V.A., Kabaeva E.N., Chichanovskaya L.V. et al. Сlinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction (results of a multicentre clinical trial). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015;8:45–52. (in Russ.). https://doi:10.17116/jnevro20151158145-52
Review
For citations:
Skripchenkko N.V., Vilnits A.A., Egorova E.S., Klimkin A.V., Voitenkov V.B., Bedova M.A. Encephalopathies of Critical Conditions: Problem and Solutions. Russian neurological journal. 2020;25(4):51-59. (In Russ.) https://doi.org/10.30629/2658-7947-2020-25-4-51-59
Views:
1238
Email this article 